Skip to main content
S 4574 116th Congress Senate Health Academic performance and assessments Child health Congressional oversight Digestive and metabolic diseases Government studies and investigations Health care costs and insurance Health care coverage and access Health care quality Health facilities and institutions Health information and medical records Health technology, devices, supplies Hospital care Long-term, rehabilitative, and terminal care Medicaid Medical education Medicare Nursing Nutrition and diet Organ and tissue donation and transplantation

Bringing Enhanced Treatments and Therapies to ESRD Recipients (BETTER) Kidney Care Act

Introduced: September 15, 2020 Introduced by: Young, Todd Republican · Indiana See on congress.gov
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 15, 2020
Read twice and referred to the Committee on Finance.
Sep 15, 2020
Introduced in Senate
 Plain-English summary Congressional Research Service

Bringing Enhanced Treatments and Therapies to ESRD Recipients (BETTER) Kidney Care Act

This bill requires the Centers for Medicare & Medicaid Services (CMS) to establish a demonstration program for Medicare beneficiaries with end-stage renal disease (ESRD).

Under the program, renal dialysis facilities, kidney disease specialists, physician practices, and other health care practitioners may form an organization that partners with certain health care entities to provide integrated care to beneficiaries with ESRD. Such care must include all covered Medicare benefits as well as transition services for transplantations, palliative care, and hospice. Each organization must have a minimum number or percentage of participating beneficiaries (350 or 60% of beneficiaries served at the organization's facilities) and must also comply with certain fiscal, governance, and quality of care requirements.

Additionally, the Government Accountability Office must study certain data that is reported to the CMS regarding pediatric dialysis care, as well as the effects of race-based corrections to a specified kidney function test on referrals of ESRD patients for transplant evaluations.

What's happening now September 15, 2020

Read twice and referred to the Committee on Finance.

 Committees of jurisdiction 1